[The role of a systemic inflammatory process in the atherogenic modification of lipoproteins and the development of hypercholesterolemia].


The aim of the investigation was the determination of the systemic inflammatory process significance as a casual factor of the atherogenic blood lipoprotein (LP) modification and hypercholesterolemia (HCE) development. The availability of the HCE and atherogenic LP in blood of the patients with chronic coronary disease was established to coincide with the… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics